ArticleCancer medicine2026
Factors Associated With Symptom Profiles Among Chinese Patients With Multiple Myeloma: A Latent Profile Analysis.
Article in Cancer medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundThis cross-sectional study aimed to identify symptom profiles and their associated factors in Chinese patients with multiple myeloma, thereby providing an evidence-based foundation for developing targeted symptom management strategies.
methodsPatients with multiple myeloma were recruited via convenience sampling from the hematology departments of three tertiary general hospitals in Zhejiang Province, China, between January and March 2024. Data collection utilized a sociodemographic and clinical characteristics questionnaire and the Chinese version of the M.D. Anderson Symptom Inventory-Multiple Myeloma Module (MDASI-MM) scale. The research conducted a latent profile analysis of symptom characteristics, followed by univariate analysis and multivariable multinomial logistic regression to examine factors associated with profile membership.
resultsThe study included 265 Chinese patients with multiple myeloma. Latent profile analysis identified three distinct symptom profiles: "Low Symptom Burden with Walking Distress" (46.7%), "Moderate Physical Symptoms with Daily Life Interference" (37.9%), and "High Global Symptom Burden" (15.4%). Multinomial logistic regression analysis demonstrated that age, marital status, combination chemotherapy status, and Eastern Cooperative Oncology Group (ECOG) performance status were significantly associated with symptom profile membership (p < 0.05). Specifically, patients of advanced age and those with higher ECOG scores were more likely to belong to the higher burden profiles, while patients receiving combination chemotherapy and those who were unmarried/divorced/widowed were more likely to belong to the low-burden profile.
conclusionsPatients with multiple myeloma exhibit heterogeneous symptom experiences, classifiable into three latent profiles. Our findings suggest that age, marital status, combination chemotherapy, and ECOG performance status may help identify patients at risk for higher symptom burden. Future longitudinal research is needed to evaluate whether profile-based interventions reduce symptom burden and improve quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.